Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.

@article{Shui2012RiskOI,
  title={Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.},
  author={Irene M Shui and James Baggs and Manish M. Patel and Umesh Parashar and Melisa D. Rett and Edward A. Belongia and Simon J. Hambidge and Jason M. Glanz and Nicola P. Klein and Eric Weintraub},
  journal={JAMA},
  year={2012},
  volume={307 6},
  pages={598-604}
}
CONTEXT Current rotavirus vaccines were not associated with intussusception in large prelicensure trials. However, recent postlicensure data from international settings suggest the possibility of a low-level elevated risk, primarily in the first week after the first vaccine dose. OBJECTIVE To examine the risk of intussusception following pentavalent rotavirus vaccine (RV5) in US infants. DESIGN, SETTING, AND PATIENTS This cohort study included infants 4 to 34 weeks of age, enrolled in the… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 31 times over the past 90 days. VIEW TWEETS